A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients

Ann Hematol. 2015 May;94(5):865-7. doi: 10.1007/s00277-014-2248-0. Epub 2014 Nov 5.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Calreticulin / genetics*
  • Female
  • Humans
  • Janus Kinase 2 / genetics*
  • Male
  • Middle Aged
  • Mutation
  • Myeloproliferative Disorders / genetics*

Substances

  • Calreticulin
  • Janus Kinase 2